ConductScience.org, home

Paper3908116

Aminoglutethimide in advanced breast cancer: clinical results of a French multicenter randomized trial comparing 500 mg and 1 g/day.

Bonneterre J and 9 others. Eur J Cancer Clin Oncol, 1985. Cited by 44 papers, by iCite.

Cite this record

ConductScience Library. Aminoglutethimide in advanced breast cancer: clinical results of a French multicenter randomized trial comparing 500 mg and 1 g/day. Papers, record 3908116. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3908116

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Aminoglutethimide in advanced breast cancer: clinical results of a French multicenter randomized trial comparing 500 mg and 1 g/day.
PubMed
Journal
Eur J Cancer Clin Oncol
PubMed
Year
1985
PubMed
Publication types
Clinical Trial, Journal Article, Randomized Controlled Trial
PubMed
Citations, by iCite
44
iCite
Relative citation ratio, by iCite
2.12
iCite
Revised in PubMed
2019-09-08
PubMed

Authors10

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Bonneterre JJ
2Coppens HH
3Mauriac LL
4Metz MM
5Rouesse JJ
6Armand JPJ P
7Fargeot PP
8Mathieu MM
9Tubiana MM
10Cappelaere PP

Source PubMed

Download CSV of authors

Topics11

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
AminoglutethimideMajor topic
Breast NeoplasmsMajor topic
Aged
Clinical Trials as Topic
Drug Administration Schedule
Female
Humans
Middle Aged
Neoplasm Metastasis
Random Allocation
Time Factors

Source PubMed

Download CSV of topics

Cited by9

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 44 citations.

PMIDTitleJournalYearIn PapersSource
8354015Dose response evaluation. Use of plasma concentration confidence intervals as a tool to predict optimal drug dose ratio.Clin Pharmacokinet1993https://conductscience.org/library/papers/8354015PubMed
7949205First generation aromatase inhibitors--aminoglutethimide and testololactone.Breast Cancer Res Treat1994https://conductscience.org/library/papers/7949205PubMed
3690808Clinical pharmacology of aminoglutethimide in patients with metastatic breast cancer.Cancer Chemother Pharmacol1987https://conductscience.org/library/papers/3690808PubMed
3427227Variations in lipoproteins during aminoglutethimide therapy.Breast Cancer Res Treat1987https://conductscience.org/library/papers/3427227PubMed
3048976Mechanisms of action of aminoglutethimide as endocrine therapy of breast cancer.Drugs1988https://conductscience.org/library/papers/3048976PubMed
2679845Treatment of breast cancer with aromatase inhibitors--current status and future prospects.Br J Cancer1989https://conductscience.org/library/papers/2679845PubMed
2013115Aminoglutethimide in advanced breast cancer: plasma levels and clinical results after low and high doses.Cancer Chemother Pharmacol1991https://conductscience.org/library/papers/2013115PubMed
1493356Aromatase inhibitors in malignant diseases of aging.Drugs Aging1992https://conductscience.org/library/papers/1493356PubMed
1283847Systemic therapy of advanced breast cancer.Drugs1992https://conductscience.org/library/papers/1283847PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/3908116

GET https://conductscience.org/api/papers/v1/3908116/authors